• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

由多种危险因素导致肝硬化的患者中,多结节性肝细胞癌的高患病率。

High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.

作者信息

Fasani P, Sangiovanni A, De Fazio C, Borzio M, Bruno S, Ronchi G, Del Ninno E, Colombo M

机构信息

FIRC-University of Milan Liver Cancer Unit, Department of Internal Medicine, IRCCS Maggiore Hospital, Milan, Italy.

出版信息

Hepatology. 1999 Jun;29(6):1704-7. doi: 10.1002/hep.510290604.

DOI:10.1002/hep.510290604
PMID:10347111
Abstract

To see whether or not there is an association between the cause of cirrhosis and the number of hepatocellular carcinoma (HCC) nodules, we analyzed 178 consecutive patients in whom HCC was detected during a prospective screening by abdominal ultrasound (US). The relevant information was obtained from the database of the screening programs operating at four hospitals in the Milan area. One hundred twenty-nine (72%) patients had a single tumor nodule detected by US and 49 (28%) patients had multinodular disease. Ninety-eight (55%) patients had normal serum values of alpha-fetoprotein (AFP). Tumor staging with biphasic computed tomography (CT) scan or hepatic arteriography with lipiodol revealed that 101 (57%) patients had single tumor nodules and 77 (43%) patients had more than one HCC nodule. After staging, multinodular HCC was more common in patients with multiple risk factors than in the hepatitis C virus (HCV) carriers (56% vs. 38%, P =.05). Interestingly, single tumors were as common in the 126 patients undergoing 6-month interval screening as in the 52 patients who were studied at yearly intervals. The former patients, however, had more small tumors than the latter ones (91% vs. 74%, P =.04). The 22 patients who were alcohol abusers had normal levels of serum AFP more often than the hepatitis B virus (HBV) or HCV carriers or those with multiple risk factors (86% vs. 57%, P <.04; vs. 47%, P <.002; vs. 52%, P <.006, respectively). We concluded that multinodular HCC was underdetected by real time US; it prevailed among patients with multiple risk factors. In these patients, screening with US exams every 6 months may be inadequate for early detection of liver cancer.

摘要

为了探究肝硬化病因与肝细胞癌(HCC)结节数量之间是否存在关联,我们分析了178例在腹部超声(US)前瞻性筛查中检测出HCC的连续患者。相关信息取自米兰地区四家医院筛查项目的数据库。129例(72%)患者经超声检测发现单个肿瘤结节,49例(28%)患者患有多结节疾病。98例(55%)患者血清甲胎蛋白(AFP)值正常。双期计算机断层扫描(CT)或碘油肝动脉造影的肿瘤分期显示,101例(57%)患者有单个肿瘤结节,77例(43%)患者有不止一个HCC结节。分期后,多结节HCC在具有多种危险因素的患者中比在丙型肝炎病毒(HCV)携带者中更常见(56%对38%,P = 0.05)。有趣的是,在每6个月进行一次间隔筛查的126例患者中,单个肿瘤的情况与每年进行一次研究的52例患者中一样常见。然而,前者的小肿瘤比后者更多(91%对74%,P = 0.04)。22例酗酒患者血清AFP水平正常的情况比乙型肝炎病毒(HBV)或HCV携带者或具有多种危险因素的患者更常见(分别为86%对57%,P < 0.04;对47%,P < 0.002;对52%,P < 0.006)。我们得出结论,实时超声对多结节HCC检测不足;它在具有多种危险因素的患者中占主导。在这些患者中,每6个月进行一次超声检查筛查可能不足以早期发现肝癌。

相似文献

1
High prevalence of multinodular hepatocellular carcinoma in patients with cirrhosis attributable to multiple risk factors.由多种危险因素导致肝硬化的患者中,多结节性肝细胞癌的高患病率。
Hepatology. 1999 Jun;29(6):1704-7. doi: 10.1002/hep.510290604.
2
Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India.肝硬化患者与非肝硬化患者肝细胞癌的危险因素分析:一项对213例来自印度的肝细胞癌患者的病例对照研究。
J Gastroenterol Hepatol. 2007 Jul;22(7):1104-11. doi: 10.1111/j.1440-1746.2007.04908.x. Epub 2007 Jun 7.
3
Etiologic factors and clinical presentation of hepatocellular carcinoma. Differences between cirrhotic and noncirrhotic Italian patients.肝细胞癌的病因及临床表现。意大利肝硬化和非肝硬化患者之间的差异。
Cancer. 1995 May 1;75(9):2220-32. doi: 10.1002/1097-0142(19950501)75:9<2220::aid-cncr2820750906>3.0.co;2-4.
4
Hepatocellular carcinoma in Belgium: clinical and virological characteristics of 154 consecutive cirrhotic and non-cirrhotic patients.比利时肝细胞癌:154例连续性肝硬化和非肝硬化患者的临床及病毒学特征
Eur J Gastroenterol Hepatol. 2000 Jan;12(1):61-6.
5
[The significance of anti-HBc and occult hepatitis B virus infection in the occurrence of hepatocellular carcinoma in patients with HBsAg and anti-HCV negative alcoholic cirrhosis].[抗-HBc及隐匿性乙型肝炎病毒感染在HBsAg和抗-HCV阴性酒精性肝硬化患者肝细胞癌发生中的意义]
Korean J Hepatol. 2008 Mar;14(1):67-76. doi: 10.3350/kjhep.2008.14.1.67.
6
Serum alpha-fetoprotein may have a significant role in the surveillance of hepatocellular carcinoma in hepatitis B endemic areas.血清甲胎蛋白在乙肝流行地区肝细胞癌的监测中可能具有重要作用。
Hepatogastroenterology. 2015 Mar-Apr;62(138):327-32.
7
Association of serum level of growth differentiation factor 15 with liver cirrhosis and hepatocellular carcinoma.生长分化因子15血清水平与肝硬化和肝细胞癌的关联
PLoS One. 2015 May 21;10(5):e0127518. doi: 10.1371/journal.pone.0127518. eCollection 2015.
8
Community-based screening for hepatocellular carcinoma in elderly residents in a hepatitis B- and C-endemic area.在乙型肝炎和丙型肝炎流行地区,对老年居民进行基于社区的肝细胞癌筛查。
J Gastroenterol Hepatol. 2011 Jan;26(1):129-34. doi: 10.1111/j.1440-1746.2010.06476.x.
9
Hepatocellular carcinoma in Germany: a retrospective epidemiological study from a low-endemic area.德国的肝细胞癌:一项来自低流行地区的回顾性流行病学研究。
Liver. 2000 Jul;20(4):312-8. doi: 10.1034/j.1600-0676.2000.020004312.x.
10
Alpha-fetoprotein as a tumor marker in hepatocellular carcinoma: investigations in south Indian subjects with hepatotropic virus and aflatoxin etiologies.甲胎蛋白作为肝细胞癌的肿瘤标志物:对南印度感染嗜肝病毒和黄曲霉毒素致病的受试者的研究
Int J Infect Dis. 2008 Nov;12(6):e71-6. doi: 10.1016/j.ijid.2008.04.010. Epub 2008 Jul 26.

引用本文的文献

1
Biological Functions and Potential Therapeutic Significance of O-GlcNAcylation in Hepatic Cellular Stress and Liver Diseases.O-糖基化在肝细胞应激和肝脏疾病中的生物学功能及潜在治疗意义。
Cells. 2024 May 9;13(10):805. doi: 10.3390/cells13100805.
2
Reconstruction of the regulatory hypermethylation network controlling hepatocellular carcinoma development during hepatitis C viral infection.重建调控性高甲基化网络,以控制丙型肝炎病毒感染期间肝细胞癌的发展。
J Integr Bioinform. 2023 Nov 20;20(3). doi: 10.1515/jib-2023-0013. eCollection 2023 Sep 1.
3
Correlation of Clinicopathological Profile, Prognostic Factors, and Survival Outcomes with Baseline Alfa-Fetoprotein Levels in Patients With Hepatocellular Carcinoma: A Biomarker that is Bruised but Not Broken.
肝细胞癌患者临床病理特征、预后因素及生存结局与基线甲胎蛋白水平的相关性:一种虽受损但未失效的生物标志物
J Clin Exp Hepatol. 2022 May-Jun;12(3):841-852. doi: 10.1016/j.jceh.2021.11.006. Epub 2021 Nov 16.
4
Computed tomography for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease.计算机断层扫描在慢性肝病成人肝细胞癌诊断中的应用。
Cochrane Database Syst Rev. 2021 Oct 6;10(10):CD013362. doi: 10.1002/14651858.CD013362.pub2.
5
PCSK9 Levels Are Raised in Chronic HCV Patients with Hepatocellular Carcinoma.慢性丙型肝炎合并肝细胞癌患者的前蛋白转化酶枯草溶菌素9水平升高。
J Clin Med. 2020 Sep 28;9(10):3134. doi: 10.3390/jcm9103134.
6
Characterizing responsive and refractory orthotopic mouse models of hepatocellular carcinoma in cancer immunotherapy.描述癌症免疫治疗中肝癌原位模型的反应性和难治性。
PLoS One. 2019 Jul 10;14(7):e0219517. doi: 10.1371/journal.pone.0219517. eCollection 2019.
7
O-GlcNAc transferase activates stem-like cell potential in hepatocarcinoma through O-GlcNAcylation of eukaryotic initiation factor 4E.O-GlcNAc 转移酶通过对真核起始因子 4E 的 O-GlcNAc 化激活肝癌中的干细胞样细胞潜能。
J Cell Mol Med. 2019 Apr;23(4):2384-2398. doi: 10.1111/jcmm.14043. Epub 2019 Jan 24.
8
Weighing the benefits of hepatocellular carcinoma surveillance against potential harms.权衡肝细胞癌监测的益处与潜在危害。
J Hepatocell Carcinoma. 2019 Jan 14;6:23-30. doi: 10.2147/JHC.S159581. eCollection 2019.
9
Herbal management of hepatocellular carcinoma through cutting the pathways of the common risk factors.通过阻断共同危险因素的途径进行肝细胞癌的草药治疗管理。
Biomed Pharmacother. 2018 Nov;107:1246-1258. doi: 10.1016/j.biopha.2018.08.104. Epub 2018 Aug 29.
10
XWL-1-48 exerts antitumor activity via targeting topoisomerase II and enhancing degradation of Mdm2 in human hepatocellular carcinoma.XWL-1-48 通过靶向拓扑异构酶 II 并增强人肝癌细胞中 Mdm2 的降解发挥抗肿瘤活性。
Sci Rep. 2017 Aug 30;7(1):9989. doi: 10.1038/s41598-017-10577-7.